Plain-English translation of NCT06395129 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing low dead-space needles and syringes — equipment designed to reduce the amount of blood left in the needle after injection, which can lower your risk of catching blood-borne infections like HIV and hepatitis. Researchers want to see if people who inject drugs prefer these safer needles and whether they actually reduce infection rates when made available at needle and syringe programs.
People who share injection equipment can catch serious infections like HIV and hepatitis C. This new equipment is designed to leave less blood in the needle, which could significantly reduce that infection risk — but researchers need to test whether it actually works in real-world settings and whether people will choose to use it.
You likely qualify if…
You likely don't qualify if…
In the first phase, you'll join a discussion group where you'll see different needle and syringe options, learn about their benefits, and share your preferences. Then you'll have a 6-week trial period where you can try the new equipment at your regular program. After that, you'll discuss your experience in another group. If you're in the longer-term study, you'll get tested for HIV and hepatitis C at the start, 6 months, 12 months, and possibly 18 months, while continuing to access the new safer equipment and other services at your program.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Armenia
Georgia
Tanzania